🔎 Trials Near Me

Dachaigh › Neoplasm Myeloproliferative › Texas › Houston

Sgrùdaidhean clionaigeach Neoplasm Myeloproliferative ann an Houston, TX

Tha 16 sgrùdaidhean airson Neoplasm Myeloproliferative a’ lorg phàirtichean aig làraichean ann agus timcheall air Houston (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

A’ fastadhÌre 1
  • The University of Texas, MD Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07469891

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

A’ fastadhSgrùdadh amharc
  • Texas Children's Hospital, Houston
Aoisean 0 gu 38 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06131801

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

A’ fastadhÌre 2
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
  • Ben Taub General Hospital, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT05564390

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

A’ fastadhÌre 1/2
  • MD Anderson, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT05320198

Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

A’ fastadhÌre 1
  • M D Anderson Cancer Center, Houston
Aoisean 1 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT03630991

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

A’ fastadhÌre 2
  • The University of Texas MD Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT04996875

Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

A’ fastadhÌre 1/2
  • M D Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT03471260

CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

A’ fastadhÌre 2
  • M D Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04493164

Project: Every Child for Younger Patients With Cancer

A’ fastadhSgrùdadh amharc
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
  • UT MD Anderson Cancer Center, Houston
Suas gu aois 25 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT02402244

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

A’ fastadhÌre 1
  • University of Texas M. D. Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Iuch 2026 · NCT07441694

Asciminib Roll-over Study

A’ fastadhÌre 4
  • Uni Of TX MD Anderson Cancer Cntr, Houston
Aoisean 7 gu 100 · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT04877522

Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers

A’ fastadhÌre 2
  • M D Anderson Cancer Center, Houston
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 22 Cèit 2026 · NCT03589729

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

A’ fastadhÌre 1
  • Md Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Gibl 2026 · NCT06034002

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

A’ fastadhSgrùdadh amharc
  • Massive Bio SYNERGY-AI site, Houston
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774

Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

A’ fastadhÌre 1
  • The University of Texas MD Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Gibl 2025 · NCT05423691

Sgrùdaidhean Neoplasm Myeloproliferative ann am bailtean eile

Sgrùdaidhean eile ann an Houston

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.